Table S2 from Preclinical Antitumor Efficacy of a Novel Anti–c-Kit Antibody–Drug Conjugate, NN3201, in c-Kit–Positive Tumors
Abstract
<p>Change in reticulocytes during dosing period</p>
Fields of Study & Subjects
Mast cells and histamine
Gastrointestinal Tumor Research and Treatment
HER2/EGFR in Cancer Research
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026